Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women

被引:195
|
作者
Papadimitropoulos, E
Wells, G
Shea, B
Gillespie, W
Weaver, B
Zytaruk, N
Cranney, A
Adachi, J
Tugwell, P
Josse, R
Greenwood, C
Guyatt, G
机构
[1] McMaster University, Department of Clinical Epidemiology, Hamilton, Ont. L8N 3Z5
关键词
D O I
10.1210/er.2001-8002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To review the effect of vitamin D on bone density and fractures in postmenopausal women. Data Source: We searched MEDLINE and EMBASE from 1966 to 1999 and examined citations of relevant articles and proceedings of international meetings. We contacted osteoporosis investigators and primary authors to identify additional studies and to obtain unpublished data. Study Selection: We included 25 trials that randomized women to standard or hydroxylated vitamin D with or without calcium supplementation or a control and measured bone density or fracture incidence for at least 1 yr. Data Extraction: For each trial, three independent reviewers assessed the methodological quality and abstracted data. Data Synthesis: Vitamin D reduced the incidence of vertebral fractures [relative risk (RR) 0.63, 95% confidence interval (Cl) 0.45-0.88, P < 0.01] and showed a trend toward reduced incidence of nonvertebral fractures (RR 0.77,95% Cl 0.57-1.04, P = 0.09). Most patients in the trials that evaluated vertebral fractures received hydroxylated vitamin D, and most patients in the trials that evaluated nonvertebral fractures received standard vitamin D. Hydroxylated vitamin D had a consistently larger impact on bone density than did standard vitamin D. For instance, total body differences in percentage change between hydroxylated vitamin D and control were 2.06 (0.72, 3.40) and 0.40 (- 0.25,1.06) for standard vitamin D. At the lumbar spine and forearm sites, hydroxylated vitamin D doses above 50 mug yield larger effects than lower doses. Vitamin D resulted in an increased risk of discontinuing medication in comparison to control as a result of either symptomatic adverse effects or abnormal laboratory results (RR 1.37,95% CI 1.01-1.88), an effect that was similar in trials of standard and hydroxylated vitamin D. Conclusions: Vitamin D decreases vertebral fractures and may decrease nonvertebral fractures. The available data are uninformative regarding the relative effects of standard and hydroxylated vitamin D.
引用
收藏
页码:560 / 569
页数:10
相关论文
共 50 条
  • [1] Efficacy and safety of odanacatib in the treatment of postmenopausal women with osteoporosis: a meta-analysis
    Li, Jiaxuan
    Qiu, Qi
    Jiang, Shide
    Sun, Jianfeng
    Pavel, Volotovski
    Li, Yusheng
    [J]. JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01):
  • [2] Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women
    Wells, G
    Tugwell, P
    Shea, B
    Guyatt, G
    Peterson, J
    Zytaruk, N
    Robinson, V
    Henry, D
    O'Connell, D
    Cranney, A
    [J]. ENDOCRINE REVIEWS, 2002, 23 (04) : 529 - 539
  • [3] Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis A Meta-Analysis
    Gu, Hai-Feng
    Gu, Ling-Jia
    Wu, Yue
    Zhao, Xiao-Hong
    Zhang, Qing
    Xu, Zhe-Rong
    Yang, Yun-Mei
    [J]. MEDICINE, 2015, 94 (44) : e1674
  • [4] The association between vitamin D receptor FokI gene polymorphism and osteoporosis in postmenopausal women: a meta-analysis
    Wang, S.
    Ai, Z.
    Song, M.
    Yan, P.
    Li, J.
    Wang, S.
    [J]. CLIMACTERIC, 2021, 24 (01) : 74 - 79
  • [5] Efficacy of the Combination of Teriparatide and Denosumab in the Treatment of Postmenopausal Osteoporosis: A Meta-Analysis
    Sun, Yang
    Li, Yue
    Li, Jiangbi
    Xie, Xiaoping
    Gu, Feng
    Sui, Zhenjiang
    Zhang, Ke
    Yu, Tiecheng
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: A meta-analysis
    Bergman, Gert J. D.
    Fan, Tao
    McFetridge, Jeffrey T.
    Sen, Shuvayu S.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) : 1193 - 1201
  • [7] Efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis A systematic review and meta-analysis
    Peng, Lihua
    Luo, Qian
    Lu, Hui
    [J]. MEDICINE, 2017, 96 (49)
  • [8] Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis
    Cranney, A
    Tugwell, P
    Adachi, J
    Weaver, B
    Zytaruk, N
    Papaioannou, A
    Robinson, V
    Shea, B
    Wells, G
    Guyatt, G
    [J]. ENDOCRINE REVIEWS, 2002, 23 (04) : 517 - 523
  • [9] Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis
    Cranney, A
    Tugwell, P
    Zytaruk, N
    Robinson, V
    Weaver, B
    Shea, B
    Wells, G
    Adachi, J
    Waldegger, L
    Guyatt, G
    [J]. ENDOCRINE REVIEWS, 2002, 23 (04) : 540 - 551
  • [10] A Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis
    A. Cranney
    G. Guyatt
    N. Krolicki
    V. Welch
    L. Griffith
    J. D. Adachi
    B. Shea
    P. Tugwell
    G. Wells
    [J]. Osteoporosis International, 2001, 12 : 140 - 151